BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9804 related articles for article (PubMed ID: 1841547)

  • 1. Age-dependent experimental tumor dissemination of murine melanoma B16.
    Baumgart J; Zippel D
    Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):489-94. PubMed ID: 1841547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the immunomodulator LS 2616 on growth and metastasis of the murine B16-F10 melanoma.
    Kalland T
    Cancer Res; 1986 Jun; 46(6):3018-22. PubMed ID: 3486041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
    Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
    In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice.
    Gorelik E
    Cancer Res; 1987 Feb; 47(3):809-15. PubMed ID: 3802083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.
    Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
    Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.
    Wiltrout RH; Herberman RB; Zhang SR; Chirigos MA; Ortaldo JR; Green KM; Talmadge JE
    J Immunol; 1985 Jun; 134(6):4267-75. PubMed ID: 3989307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cure of B16F10 melanoma lung metastasis in mice by chronic indomethacin therapy combined with repeated rounds of interleukin 2: characteristics of killer cells generated in situ.
    Lala PK; Parhar RS
    Cancer Res; 1988 Mar; 48(5):1072-9. PubMed ID: 3124954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy of metastases with lymphocytes treated with exogenous RNA in mice bearing B16 melanoma.
    Watanabe MA; Almeida DO; Serrano SV; Sales VS; Soares FA; de Lucca FL
    Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):393-8. PubMed ID: 9193794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response.
    Wack C; Kirst A; Becker JC; Lutz WK; Bröcker EB; Fischer WH
    Cancer Immunol Immunother; 2002 Oct; 51(8):431-9. PubMed ID: 12202904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradication of melanoma pulmonary metastases by immunotherapy with tumor cells engineered to secrete interleukin-2 or gamma interferon.
    Abdel-Wahab Z; Dar M; Osanto S; Fong T; Vervaert CE; Hester D; Jolly D; Seigler HF
    Cancer Gene Ther; 1997; 4(1):33-41. PubMed ID: 9012449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine modulation of tumor metastases. I. Effect of adrenalectomy on B16 melanoma metastases.
    Kitson RP; Brunson KW; Miller CA; Goldfarb RH
    In Vivo; 1994; 8(5):803-6. PubMed ID: 7727728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimetastatic action of polyactin A and its mechanism].
    Qiang WA; Liu JR; Wang YS; Lei YD
    Yao Xue Xue Bao; 1994; 29(5):340-5. PubMed ID: 7976351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of combined therapy with lymphokine-activated killer cells, interleukin 2 and specific monoclonal antibody on established B16 melanoma lung metastases.
    Eisenthal A; Cameron RB; Uppenkamp I; Rosenberg SA
    Cancer Res; 1988 Dec; 48(24 Pt 1):7140-5. PubMed ID: 3263900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of lung metastases and natural killer cell activity in daily fractions and weekly fractions of radiation therapy on murine B16a melanoma.
    Shen RN; Hornback NB; Shidnia H; Lu L; Montebello JF; Brahmi Z
    Radiat Res; 1988 May; 114(2):354-60. PubMed ID: 3375430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against experimental cerebral metastases of murine melanoma B16 by active immunization.
    Staib L; Harel W; Mitchell MS
    Cancer Res; 1993 Mar; 53(5):1113-21. PubMed ID: 8439956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimetastatic activity induced by Clostridium butyricum and characterization of effector cells.
    Chen HY; Wu SL; Yeh MY; Chen CF; Mikami Y; Wu JS
    Anticancer Res; 1993; 13(1):107-11. PubMed ID: 8476200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune regulation of metastasis from in vivo derived syngeneic murine melanoma.
    Harning R; Koo GC; Szalay J
    Reg Immunol; 1990; 3(2):97-102. PubMed ID: 1965137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of murine melanoma with bryostatin 1.
    Schuchter LM; Esa AH; May S; Laulis MK; Pettit GR; Hess AD
    Cancer Res; 1991 Jan; 51(2):682-7. PubMed ID: 1985785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice.
    Pearlstein E; Ambrogio C; Karpatkin S
    Cancer Res; 1984 Sep; 44(9):3884-7. PubMed ID: 6744304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressive effect of Zedoariae rhizoma on pulmonary metastasis of B16 melanoma cells.
    Seo WG; Hwang JC; Kang SK; Jin UH; Suh SJ; Moon SK; Kim CH
    J Ethnopharmacol; 2005 Oct; 101(1-3):249-57. PubMed ID: 16023317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 491.